Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N F Hacker

Showing results (101-110 of 123) with videos related to

Pageof 13
Sort By:
Gynecologic Oncology|February 1, 1983
Estrogen and progesterone receptor sites in malignancies of the uterine cervix, vagina, and vulvaL C Ford, J S Berek, L D Lagasse, et al.
Obstetrics and Gynecology|January 1, 1985
Adenocarcinoma of the uterine cervix: histologic variables associated with lymph node metastasis and survivalJ S Berek, N F Hacker, Y S Fu, et al.
Cancer|November 26, 1999
Adjuvant small field pelvic radiation for patients with high risk, stage IB lymph node negative cervix carcinoma after radical hysterectomy and pelvic lymph node dissection. A pilot studyF J Kridelka, D O Berg, M Neuman, et al.
Gynecologic Oncology|July 1, 1989
Utilization of a murine model to optimize volume and dwell time of intraperitoneal cisplatinR G Pretorius, S Eisenkop, J S Berek, et al.
Cancer Genetics and Cytogenetics|August 25, 2001
High frequency of allelic imbalance at regions of chromosome arm 8p in ovarian carcinomaI Pribill, P Speiser, J Leary, et al.
Gynecologic Oncology|October 24, 1998
p53 protein overexpression: a strong prognostic factor in uterine papillary serous carcinomaD Bancher-Todesca, G Gitsch, K E Williams, et al.
Cancer Treatment Reports|December 1, 1983
Pharmacokinetics of Ip cisplatin in refractory ovarian carcinomaR G Pretorius, N F Hacker, J S Berek, et al.
Obstetrics and Gynecology|November 1, 1984
Lymphocyte cytotoxicity in the peritoneal cavity and blood of patients with ovarian cancerJ S Berek, R C Bast, A Lichtenstein, et al.
British Journal of Cancer|October 3, 1999
Hormone replacement therapy and risk of epithelial ovarian cancerD M Purdie, C J Bain, V Siskind, et al.
Gynecologic Oncology|June 1, 1983
Estrogen and progesterone receptors in ovarian neoplasmsL C Ford, J S Berek, L D Lagasse, et al.
Pageof 13

Showing results (101-110 of 123) with videos related to

Sort By:
Pageof 13
Gynecologic Oncology|February 1, 1983
Estrogen and progesterone receptor sites in malignancies of the uterine cervix, vagina, and vulvaL C Ford, J S Berek, L D Lagasse, et al.
Obstetrics and Gynecology|January 1, 1985
Adenocarcinoma of the uterine cervix: histologic variables associated with lymph node metastasis and survivalJ S Berek, N F Hacker, Y S Fu, et al.
Cancer|November 26, 1999
Adjuvant small field pelvic radiation for patients with high risk, stage IB lymph node negative cervix carcinoma after radical hysterectomy and pelvic lymph node dissection. A pilot studyF J Kridelka, D O Berg, M Neuman, et al.
Gynecologic Oncology|July 1, 1989
Utilization of a murine model to optimize volume and dwell time of intraperitoneal cisplatinR G Pretorius, S Eisenkop, J S Berek, et al.
Cancer Genetics and Cytogenetics|August 25, 2001
High frequency of allelic imbalance at regions of chromosome arm 8p in ovarian carcinomaI Pribill, P Speiser, J Leary, et al.
Gynecologic Oncology|October 24, 1998
p53 protein overexpression: a strong prognostic factor in uterine papillary serous carcinomaD Bancher-Todesca, G Gitsch, K E Williams, et al.
Cancer Treatment Reports|December 1, 1983
Pharmacokinetics of Ip cisplatin in refractory ovarian carcinomaR G Pretorius, N F Hacker, J S Berek, et al.
Obstetrics and Gynecology|November 1, 1984
Lymphocyte cytotoxicity in the peritoneal cavity and blood of patients with ovarian cancerJ S Berek, R C Bast, A Lichtenstein, et al.
British Journal of Cancer|October 3, 1999
Hormone replacement therapy and risk of epithelial ovarian cancerD M Purdie, C J Bain, V Siskind, et al.
Gynecologic Oncology|June 1, 1983
Estrogen and progesterone receptors in ovarian neoplasmsL C Ford, J S Berek, L D Lagasse, et al.
Pageof 13